Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2006 / N 4

Эмфизема легких (Список литературы)
А.В. Аверьянов, Г.Э. Поливанов

1. Ruysch F. Observationem Anatomico-Hirurgircarum.// Amsterdam: Henricum Boom, 1691, p 25-27
2. Baillie M. :A series of engravings, accompanied with explanations which are intended to illustrate the morbid anatomy of some of the most important parts of the human body.// London: W. Bulmer, 1799.
3. Laennec R. A treatise on the diseases of the chest on mediate auscultation. (Translated by J. Forbes).// Fourth London edition. Philadelphia: Thomas& Co., 1835, pp. 135-163.
4. Изаксон Э.
5. Orsos F.: Au Uber das elastische Gerauust der normalen und der emphysematosen Lunge.// Pathol. Anat. 41: 95-121, 1907.
6. Harris WH, Chillingworth FP. The experimental production in dogs of emphysema with associated asthmatic syndrome by means of an intratracheal ball valve.// J Exp Med 1919;30:75–85.
7. Gough J: Discussion on the diagnosis of pulmonary emphysema: The pathological diagnosis of emphysema. //Proc R Soc Med 45: 576-577, 1952.
8. Laurell CB, Erickson S. The electrophoretic a1-globulin pattern of serum in a1-antitrypsin deficiency.// Scan J Clin Lab Invest 1963;15:132–140
9. Gross P, Babjak M, Tolker E, et al. Enzymatically produced pulmonary emphysema: A preliminary report.//J Occup Med 1964; 6:481-484
10. Mercer R., Crapo J. D. Structural changes in elastic fibers after pancreatic elastase administration in hamsters. //J. Appl. Physiol. 1992; 72: 1473-1479
11. Vlanovich G, Russel ML, Mercer RR, Crapo JD . Cellular and Connective Tissue Changes in Alveolar Septal Walls in Emphysema //Am. J. Respir. Crit. Care Med., Vol 160, Number 6, 1999, 2086-2092
12. National Heart Lung and Blood Institute. The definition of emphysema. Report of a Division of Lung Diseases workshop.// Am Rev Respir Dis 1985;132:182–185.
13. Mason RJ, Murray JF, Broaddus VC, Nadel JA. Textbook of Respiratory Medicine.// Fourth Edition, Elsevier inc., USA 2005, Vol 1. P 1117.
14. Joyce E. : Rundhaug Matrix metalloproteinases and angiogenesis// J. Cell. Mol. Med. Vol 9, No 2, 2005 pp. 267-285
15. Finlay, GA, O’Driscoll, LR, Russell, KJ, et al: Matrix metalloproteinase expression and production by alveolar macrophages in emphysema.// Am. J. Respir. Crit. Care Med., Volume 156, Number 1, July 1997, 240-247
16. Ohnishi K, Takagi M, Kurokawa Y et al: Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema// Lab Investig (1998) 78: 1077-1087
17. Vernooy J, Lindeman J H, Jacobs JA: Increased Activity of Matrix Metalloproteinase-8 and Matrix Metalloproteinase-9 in Induced Sputum From Patients With COPD// Chest. 2004;126:1802-1810
18. Selman M, Cisneros-Lira J, Gaxiola M et al: Matrix metalloproteinases inhibition attenuates tobacco smoke-induced emphysema in guinea pigs. Chest (2003) 123: 1633-1641.
19. Voelkel N. F., Vandivier R. W, Tuder R. M .Vascular endothelial growth factor in the lung //Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L209 - L221
20. Santos S, Peinado VI, Ramirez J et al: Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease.//Am J Respir Crit Care Med (2003) 167: 1250-1256
21. Kranenburg A R et al. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease // Thorax 2005;60:106-113
22. Tudern RM, Zhen L, Cho CY. Oxidative Stress and Apoptosis Interact and Cause Emphysema Due to Vascular Endothelial Growth Factor Receptor Blockade.// Am J of Respir Cell and Molec Biol. 2003.Vol. 29, pp. 88-97
23. Henson P.M., Vandivier RW, Douglas S.I. Cell Death, Remodeling, and Repair in Chronic Obstructive Pulmonary Disease?// The Proceedings of the American Thoracic Society (2006)3:713-717
24. Fang KC, Wolters PJ, Steinhoff M, et al.: Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta.// J Immunol 1999;162:5528–35
25. Kucich U, Rosenbloom JC, Abrams WR, et al.: Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta and p38.// Am J Respir Cell Mol Biol 2002;26:183–8
26. Bonniaud P, Kolb M, Galt T et al: Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis.//J Immunol 2004;173:2099–2108
27. Pons R, Sauleda J., Noguera A. et al: Decreased macrophage release of TGF-β and TIMP-1 in chronic obstructive pulmonary disease // Eur. Respir. J., July 1, 2005; 26(1): 60 – 66
28. Aoshiba K, Nagai A.:Differences in airway remodeling between asthma and chronic obstructive pulmonary disease.//Clin Rev Allergy Immunol 2004;27:35–43
29. Hodge S, Hodge G, Scicchitano R et al: Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells.// Immunol Cell Biol. 2003;81:289–296.
30. Vandivier RW, Fadok VA, Hoffmann PR et al: Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis.// J Clin Invest. 2002;109:661–670
31. Choe KH, Taraseviciene-Stewart L, Scerbavicius R et al Methylprednisolone causes matrix metalloproteinase–dependent emphysema in adult rats.// Am J Respir Crit Care Med 2003;167:1516–1521
32. Stein J, Fenigstein H. Pathological anatomy of hunger disease.// In: Winick M, editor. Hunger disease: studies by the Jewish physicians in the Warsaw Ghetto: current concepts in nutrition. New York: John Wiley & Sons; 1979. p. 207–211
33. Kerr JS, Riley DJ, Lanza-Jacoby S, et al. Nutritional emphysema in the rat // Am Rev Respir Dis 1985;131:644–650
34. Coxson H., Ida H. Chan T., Mayo J Early Emphysema in Patients with Anorexia Nervosa// Am J Respir and Crit Care Med 2004;Vol 170. pp. 748-752
35. Uppaluri R, Mitsa T, Sonka M et al. Quantification of pulmonary emphysema from lung computed tomography images.// Am J Respir Crit Care Med 1997;156:248–254
36. Sanders C, Nath PH, Bailey WC.: Detection of emphysema with computed tomography: correlation with pulmonary function tests and chest radiography.// Invest Radiol 1988;23:262–266
37. Власов П.В. Лучевая диагностика заболеваний органов грудной полости// «Видар», 2006, стр.65-77
38. Morgan MDL.: Detection and quantification of pulmonary emphysema by computed tomography: a window of opportunity.// Thorax 1992;47:1001–1004
39. Müller NL, Stapels CA, Miller RR, Abboud RJ:. "Density Mask": an objective method to quantitate emphysema using computed tomography.// Chest 1988;94:782–787
40. Gevenois PA, de Maertelaer V, De Vuyst P et al.: Comparison of computed density and macroscopic morphometry in pulmonary emphysema.// Am J Respir Crit Care Med 1995;152:653–657
41. Chapman K.R., Stockley R.A., Dawkins C. et al . Augmentation therapy for α1-antitrypsin deficiency: a meta-analysis of randomized and non-randomized clinical studies.// Eur. Respir. J. 2005; 26 (49): 288
42. Wencker M., Fuhrmann B., Banik N. et al. Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor.// Chest. 2001; 119:737-744.
43. Lieberman J. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data.// Chest 2000; 118:1480–1485.
44. Troosters T, Gosselink R, Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial.// Am J Med 2000;109:207–212.
45. Finnerty JP, Keeping I, Bullough I, Jones J: The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: randomized controlled trial// Chest 2001; 119: 1705-1710.
46. Brantigan O, Mueller E Surgical treatment of pulmonary emphysema.// Am Surg 1957. 23,789-804.
47. Cooper, JD, Trulock, EP, Triantafillou, AN, et al: Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease.// J Thorac Cardiovasc Surg (1995) 109,106-116.
48. Meyers BF, Yusen RD, Guthrie TJ, et al: Results of lung volume reduction surgery in patients meeting a national emphysema treatment trial high-risk criterion. //J Thorac Cardiovasc Surg 2004. 127:829-835
49. Tutic M, Lardinois D, Imfeld S.: Lung-Volume Reduction Surgery as an Alternative or Bridging Procedure to Lung Transplantation.// Ann Thorac Surg 2006; 82:208-213.
  

[ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]